Sayre Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.03 M
- Paid Up Capital ₹ 2.88 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 36.50 Cr
- Satisfied Charges ₹ 18.30 Cr
- Revenue Growth 22.31%
- Profit Growth 43.78%
- Ebitda 126.25%
- Net Worth -3.49%
- Total Assets 10.59%
About Sayre Therapeutics
Sayre Therapeutics Private Limited (STPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 April 2015 and has a history of Ten years and one month. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.03 M and a paid-up capital of Rs 2.88 M.
The company currently has active open charges totaling ₹36.50 Cr. The company has closed loans amounting to ₹18.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahendran Balachandran, Shukrit Chimote, and Sasidharan Rajesh serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110KA2015PTC079687
- Company No.
079687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Healthcare
Pharma
Sayre Therapeutics Private Limited
Explore comprehensive data for Sayre Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sayre Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shukrit Chimote  | Director | 07-Apr-2015 | Current |
| Mahendran Balachandran | Director | 30-Jun-2015 | Current |
| Sasidharan Rajesh | Director | 23-Dec-2021 | Current |
Financial Performance of Sayre Therapeutics.
Sayre Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.31% increase. The company also saw a substantial improvement in profitability, with a 43.78% increase in profit. The company's net worth dipped by a decrease of 3.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sayre Therapeutics?
In 2023, Sayre Therapeutics had a promoter holding of 86.44% and a public holding of 13.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Probe Information Services Private LimitedMahendran Balachandran is a mutual person
Power2sme Private LimitedMahendran Balachandran is a mutual person
Accel India Advisors LlpMahendran Balachandran is a mutual person
- Accel India Management Llp
Mahendran Balachandran is a mutual person
Wrogn Private LimitedMahendran Balachandran is a mutual person
Charges (Loans)
Open Charges
₹365.00 M
Satisfied Charges
₹183.00 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 18.00 Cr
- Others : 10.00 Cr
- Hdfc Bank Limited : 8.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2023 | Axis Bank Limited | ₹18.00 Cr | Open |
| 29 Nov 2021 | Hdfc Bank Limited | ₹8.50 Cr | Open |
| 26 Jul 2021 | Others | ₹10.00 Cr | Open |
| 29 Apr 2019 | Hdfc Bank Limited | ₹6.30 Cr | Satisfied |
| 27 Dec 2017 | Hdfc Bank Limited | ₹5.00 Cr | Satisfied |
How Many Employees Work at Sayre Therapeutics?
Sayre Therapeutics has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sayre Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sayre Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sayre Therapeutics
Recent activity within the organization
- Annual General Meeting
Sayre Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Sayre Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Charges
A charge with Axis Bank Limited amounted to Rs. 180.00 M with Charge ID 100808839 was registered on 12 Oct 2023.
- Director Appointment
Sasidharan Rajesh was appointed as a Director was appointed as a Director on 23 Dec 2021 & has been associated with this company since 3 years 4 months .
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 85.00 M with Charge ID 100516460 was registered on 29 Nov 2021.
- Charges
A charge registered on 29 Apr 2019 via Charge ID 100262942 with Hdfc Bank Limited was fully satisfied on 01 Sep 2021.
Recent News, Updates & Announcement
- Sayre Therapeutics raises $8 million from Accel, Aarin Capital | Mint.
Bengaluru-based Sayre Therapeutics, a super- speciality pharma company, has also raised $1 million in venture-debt from InnoVen Capital.
Frequently asked questions
What is the Incorporation or founding date of Sayre Therapeutics Private Limited?
Sayre Therapeutics Private Limited was incorporated on 07 Apr 2015.
What is authorized share capital and paid-up capital of Sayre Therapeutics Private Limited?
The authorized share capital of Sayre Therapeutics Private Limited is ₹ 3.03 M and paid-up capital is ₹ 2.88 M.
Who are the current board members & directors of Sayre Therapeutics Private Limited?
Currently 3 directors are associated with Sayre Therapeutics Private Limited.
- Mahendran Balachandran
- Shukrit Sudhir Chimote
- Sasidharan Rajesh
What is the registered address of Sayre Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sayre Therapeutics Private Limited is Flat No.1104 Sobha Cinnamon Apartment Haralur Road, India, Somasundara Palya, Karnataka, 560102.
What is the corporate identification number (CIN) and company number of Sayre Therapeutics Private Limited?
The corporate identification number (CIN) of Sayre Therapeutics Private Limited is U85110KA2015PTC079687 and the company number is 079687 as per Ministry of Corporate Affairs (MCA).
What is the official website of Sayre Therapeutics Private Limited?
The Official website of Sayre Therapeutics Private Limited is https://www.sayretherapeutics.com
What has been the recent revenue trend for Sayre Therapeutics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Sayre Therapeutics Private Limited has risen by 22.31%.
How many employees does Sayre Therapeutics Private Limited currently have?
As Per 2023 financial reports, 25 employees are currently employed by Sayre Therapeutics Private Limited.
What change has been observed in the net worth of Sayre Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Sayre Therapeutics Private Limited has experienced an downturn of -3.49%.
What are the total open charges for Sayre Therapeutics Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Sayre Therapeutics Private Limited amount to ₹ 36.50 Cr.
When was the last Balance Sheet of Sayre Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Sayre Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Vandana SubramanianDirectorRM
Rajesh MoortiDirectorPS
Praveenbose SivasankaranDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India